Networks
The WHO Programme for International Drug Monitoring (PIDM)
In 1963, during the 16th World Health Assembly, resolution 16.36 called for “a systematic collection of information on serious adverse drug reactions during the development and particularly after medicines have been made available for public use”. This led to the formation of the WHO Programme for International Drug Monitoring (PIDM) in 1968.
WHO promotes PV at country level. Initially the WHO PIDM members consisted of 10 countries. Now, over 170 countries and territories are part of the Programme as full or associate members.
Please visit the dedicated page to learn more about the Programme.
The Vaccine Safety Net (VSN)
Due to the success of immunization, some diseases are no longer perceived as a threat. Certain groups have even questioned the utility of vaccination in spite of its proven success in controlling disease. In recent years, a number of websites providing unbalanced, misleading and alarming vaccine safety information have been established, which can lead to undue fears, particularly among parents and patients. Acknowledging the above-mentioned issues and urged by governments, key non-governmental organizations and the United Nations Children's Fund (UNICEF), WHO initiated, in 2003, the Vaccine Safety Net (VSN) project.
Please visit the dedicated page to learn more about the project.
WHO Collaborative Centres (WHO CC)
The WHO Pharmacovigilance team works with the WHO Collaborating centers to advance pharmacovigilance in countries. These include: the Uppsala Monitoring Centre (UMC) and the Pharmacovigilance Program of India (PvPI).
Please visit the dedicated page to learn more about these centres.